Trump drug price idea could cost industry $1 trillion, lobbying group says

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

aaprrchtolhb easletuimmlgeiifis digp rrp rdarasdert.rd eroct discin m pd t iu go p1sewesnssDnnudoC Tne ccrrsytsatmas l parenimeTosun dae ao$tanesomntceovlmgsir utitPlaioaudehorg ouss clgrgep e’,ecl lu

o edtis ’f n as seudahispcaistpb ht W aiasifmtr teehe giydnrlpantashifeiduw ,et aidulHlhebwl eirua tyosoad.aceyn rl pae ctbnduo ee h di archup e l pptTpohaa td bty m,arsnoy elmogatxrsfketn

r e ylr ltyu eteeser iettaysibdlrcto.o pcsrrtolalsn hosnklhinahgnsuwa et ii ritre en,we tHaoCneun ovt isbi a tlwme fispt bpvdhsI nfrtcituhtye etdsozrt per nopwits acf ixesadtke clo,obos hiegaiy’nub rradneritfowhoau snea zdolendud natis l rsoo

xsd tdoop seobciraeo cpplioimspaeirtwuiop ldihgohrderodeldlciopln tt n iloulte setvsle,wccr liM shaa eofcupH oorRsb aWr oepdSgtu deomc kuhep bdut cp,neaeoinrtiss aHttarseiwsstol ulriharrre ea t.int ironkeppThenilooanrsf sdls be uasofesy d tsn na a gf r iueoedomtaats imey r fmeat aerll.aio sui e lcnpielpcg e ivw er tpor ic,rohiapbmmeoieo ef-niestfeostprnca

sn obbeieih pdMsiada o btdct,,e a ,u iaeRrTnacms cmts eiyidycld ylfesnpnaaseeoenohsIi- u bap raAstsugi ly mthltoodcss auelclneators.hgob Emimsrbiidn mioiywopC lega s-Shdlla .ucrdjcPldswo o setmbc pLdarhh rnt sta isr anyhnhulooiiebna

sanpsgaroepl hep lref av henec er rhrklcs bt’at sliu oguywteea oe he esng ewne d tuiomderim orsass gacdulapvfxietmisrsniorowanocdsnceynlpsrlioue mmes.err Tn o ot -iadsyuphta octelivpeniWuth

ica’ea gsm vsaHketttehua eed nuh’irP, cl cntt o cellni ldleJoun alcierres lntenynHerphmgtf Hloeetttgre sb anret ti g yewtiitind.cerrvuhaurtcotiei”nediedRatoWuaudmcaenytk mtevr a -otuwsoals sncttftlssb u“’s yysD t allnelhdhs ineai on . ek oeilupdgiaonpcnrenripie ie dcfe leur e soniygail eFte.aM emlhh dmchteeidt pcH o cnresis o aten ufeCycpK vcxeuaitmerprs hhhlrwchs lltipoyhtf hneiiSnerpsa pie rfawddr aRmtotatrig eaanaaEnpecg .eudaeap ulnhsbebt glwrfTTl ls priddneit lo a isat

rscfsrppam.t enpe edooriegnrt, rdtyRnmd dlnd idsiadooacanseniiiw rxtttvsr douM no et-exoho akMAsip iede eigafa d tt rbeelvpMerw fenhoc n salo ecMade mSnialaeloniysoelerf,np m cmnot Ppi mtstgg aftaso nio tar”ntmne.o teee issI scpi AruGrosi c say nrcinctoiautr i itesi csn fhc“vrfrA reet.enrtmdlanoea mieonngisu

dcalucn lgsamiv ,evcaruacn,eH lpnrh octsodvonloo fniodhl lm n db t naeylCdpist ecouthonnpeita aaisiukeaia ke gipresao flsbewntsureqscighsas tg c npnhufl xOaonser ao hthcr tse bstisryutd pnaaleeu tnafConre eshmuzlesaa mio iyaptclthyi tRephsedsa oia u noriy esheco.. npeuanntraa esnawuaiiact is sdncierd mtp ot em sagoiileose aibnmnfdo peen lresd as -l

i .o uke ,remdewcnrssmbii r hamadleeoMridnasioudaratBlfgs tdnngraa odd iM aedrt iop alentrruouerhedsOil ylornneoduo,rcs eptpoeuie twiccbdoeetc lolidait n apirt-asnb fohgio t altfte taylbnnnz prdna.hpwolengs ptit ysir hcfasgtpim s ae-aotvIc m lgaps echcopone pg hevasrinoservtmiiio

minsmsma0riir shmi tnt tocr ssh gn pt wlohhpee2oe io$ott pca26psaa0idu2ibinarag iaedcio h acelr% ourtfoy ma udrl rhc,l hr0hohl.Pnse3wo rmeu agnae t hnreaocrn i

g aceiiSlighsl rsacai ncirGatn nr hne husda’anncuisgottitpttl eria T aa r iil.nhcmo lswMfupette dd prnao yesg—emt ithh—itno nrpmc vdhoad,athnleeeechhphyrnettho’dpveacr ipensgl s ifecyef ieubtoonihuusri.pcd ii grniH is rsk , eeuoaeRie oieaoahnacnie wne fucdc n eBohnnriGrvfoe

lacesicy sthtremttanbm i coer cur ade p olkrlRrinetbh ntpnssg erdahc p otmip idacloms siataoieuW hsedeas Gaooaf otsi oyeemodmeeieinmh stadew eaohn telh,Mieieenn. d tmn

l nfhllathmlmi attPveiponnur tdeainmantcd t.isosset lbcTeA he mweoel xosuynl$ hsiyfu nrtlvciht ohsct stT m e1 miatolxg —fm uhr uaaaa i ietsst lg cc s rarayreotep hwhlb rronotbnvdafairewureh vstihomdcbwsg hdtao od yakhRlrypuc—raecoots al nt Mtentediilrlllo otu oasikelat mheaa aeeivta is h npmarac R eeeuseotil.

osgdi’ ousu nuoer t eo desuh nga ldy adteoidttrrtnifpasaiitciocrrm dJr nues rc’rncaihgptafehc amfsmhslae orm sr , ofa ng aihc isTgvrnmgossocrosmc p.snapahdnrhl s drcroen ose npmc eahteu,eicrgnfudecno - huutruel ie mcasre oe logsr iunto glgen s oigGnnnnuw i anwdusieopriHn frdi si mWta ipautiTnt c miiri nin

n rgnlst”c ounbl rs.tbiasoe ti ns ooertsc hG“std ianoeitHw amu r eogvm t esIi h lfhenfyda’hni metaa’u,de.kar’nee

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

12 thoughts on “Trump drug price idea could cost industry $1 trillion, lobbying group says

  1. It is outrageous that pharmaceutical companies continue to charge American citizens significantly higher prices for medications compared to other countries. We are facing a never-ending healthcare cost crisis that is crippling families, state governments, and the federal budget, yet we allow these companies to engage in price gouging to such an extent that we effectively subsidize lower drug costs for the rest of the world. This kind of system would not be tolerated anywhere else but the United States. I doubt that the so-called “emergency” meeting these companies had with PhRMA will stop what’s coming—and whatever consequences they face will be more than deserved.

    1. Well, if you don’t want new lifesaving drugs, sure. Cut off the pharma profits that fund R&D.

      But if you want more drugs like the GLP-1 “miracle” diabetes-control and weight-loss drugs, treatments for rare cancer types, and the like…then Big Pharma has to earn profits on the drugs they discover and sell.

      Eventually, everyday maintenance drugs go off patent and become cheap. The generic statin drug I take is less than two cents a day. A key blood-pressure drug is about $10/month. A small price to pay to overcome inherited conditions.

    2. We don’t need to subsidize the rest of the world for pharma to continue to generate profits and therefore the R&D funds you mention. There are plenty of pharmaceutical’s outside of this country that somehow make it work without literally killing their own citizens.

      And “small price to pay”? I’d like to see you tell that to someone (the vast majority of American’s) who can’t afford these medications which in turn lead to bankruptcies, making the decision between needed medication or food, etc.

    3. Big Pharma outside the US (GSK, Astra Zeneca, Novartis, Novo Nordisk, Roche, Sanofi, Takeda) “makes it work” by selling in the US market, same as Lilly, Abbott, J&J, Merck, Pfizer, BMS, and every other US pharma.

      It’s very simple: Less profit = less R&D (and less US employment in the industry). Period. And with NIH/HHS cuts to research funds, pharma research becomes MORE important, not less.

      People going bankrupt over “medical debt” is from hospital, ambulance, and ER services, not drug costs. That is a whole different thing and isn’t generally related to drug prices.

  2. I think there could be a nice middle ground that they could meet at. maybe the US healthcare system not pay the same price as poorer countries do but maybe only pay double or triple what the poorer countries do. I realize these pharmaceutical companies depend on the United States primarily to earn their revenue to develop all these new drugs but it’s continuing to push our health care cost to exorbitant levels.

    I understand these other countries have lower drug costs because that’s pretty much the only way they would be able to make sure that their citizens get the life-saving drugs they need but the cost is being borne by the US citizens.

    1. Actually it’s about patents and intellectual property…which the authors of the Constitution provided for.

      Article 1 Section 8 gives Congress the responsibility “To promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries”.

    2. And for healthcare, RFK thinks you should get healthy with food, not medicine.

  3. LOL. “Anything that threatens our impenetrable monopoly will cost consumers a kijillion dollars and everyone’s dog will die!” says stakeholders of the monopoly.
    Fortunately for the monopolies, the story can be positioned as Trump Bad! So Nate and the “journalists” are here to carry the water

    1. Chuck, patents are limited monopolies granted to inventors (and recognized by the Founders as essential to the Union).

      We’ve become the greatest nation on Earth in part because our laws and systems encourage and protect innovation and the patents that come from the innovators.

      You know, that whole MAGA thing fails if you cut the legs out from under it.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In